NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
NPCE is expected to report earnings to fall 24.65% to -19 cents per share on November 11
Q3'25
Est.
$-0.20
Q2'25
Missed
by $0.04
Q1'25
Beat
by $0.03
Q4'24
Beat
by $0.07
Q3'24
Beat
by $0.08
The last earnings report on August 12 showed earnings per share of -25 cents, missing the estimate of -21 cents. With 35.17K shares outstanding, the current market capitalization sits at 317.91M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NPCE showed earnings on August 12, 2025. You can read more about the earnings report here.